Concepedia

Lihong Ding

LD

Statistics

Publications

1

Citations

10

H-Index

1

Active since

2021

Affiliations

First Affiliated Hospital of Xiamen University(Current)

Lihong Ding is an author at First Affiliated Hospital of Xiamen University specializing in myc-mediated apoptosis, chronic myeloid leukemia therapy, and pi3k-akt signaling pathway.

Publications per year

2021–2021

1

Publications

1

Simvastatin potentiates the cell-killing activity of imatinib in imatinib-resistant chronic myeloid leukemia cells mainly through PI3K/AKT pathway attenuation and Myc downregulation

Lihong Ding, Qinwei Chen, Kai Chen et al. · European Journal of Pharmacology · 2021 · 10 citations

, , +8

1–1 of 1